We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

Modern Medicine Network
  • Login
  • Register
Skip to main content
Modern Medicine Network
  • Login
  • Register
Menu
User
Home
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

SUBSCRIBE: Print / eNewsletter

Experts See Oncology Reimbursements Headed Down, Hard Negotiations With Payers Lie Ahead

Apr 1, 2006
Volume: 
15
Issue: 
4
  • Palliative and Supportive Care

WASHINGTON—Reimbursements for oncology practices have fallen sharply since 2003, and cash flow is becoming a major concern for community cancer clinics, according to two leaders in community oncology. Drawing on recent data as well as their own experience, Steve M. Coplon, MHA, chief executive officer of The West Clinic, Memphis, Tennessee, and Dawn Holcombe, MBA, executive director of the Connecticut Oncology Association, discussed the impact of the Medicare Modernization Act (MMA) at the first annual meeting of the Community Oncology Alliance.

"We're at war," Mr. Coplon said. He cited a recent PricewaterhouseCoopers report that has projected a decrease in oncology reimbursements of $15.7 billion over the next 10 years. This is four times higher than the $4.2 billion Congress intended when it passed the MMA.

The aim of the MMA was to lower Medicare payments for chemotherapy by changing the way oncologists charged for drugs. Under the old system, physicians charged Medicare the average wholesale price (AWP) of the drug, which was normally higher than the actual price the physician paid. The excess payment covered the cost of administering the chemotherapy in the doctor's office. "AWP was deliberately designed by Congress and CMS [Centers for Medicare & Medicaid Services] to provide a cross-subsidy for admitted under-reimbursement for professional services—it's in writing," Mr. Coplon said.

But in the late 1990s, more expensive drugs and the increasing use of multiple chemotherapy agents caused a jump in reimbursements, amounting to a 267% increase over a 5-year period. The result was a series of hearing and reports and, eventually, the MMA of 2003.

Under the new law, reimbursement changes have been phased in. Oncology practices were reimbursed at 85% of the AWP in 2004, plus, to mitigate losses from steep cuts, CMS added $500 million of billable revenue to cover the shortfall in practice expenses.

In 2005, the Medicare reimbursement formula was permanently changed to the average sales price (ASP) plus 6%, with about $300 million of potential revenue made available through the chemotherapy demonstration project.

The demonstration project allowed oncologists to bill Medicare for assessing the symptoms of pain, fatigue, and nausea, replacing some of the revenue lost and providing CMS with data on quality of care.

Pages

  • 1
  • 2
  • 3
  • next ›
  • last »

Related Articles

  • Effective Palliative Care: What Is Involved?
  • Anti–Oral Mucositis Drug Granted Breakthrough Status
  • QOL Boost Seen From Early, Systematic Palliative Care in Patients With Advanced Solid Tumors
  • Early Palliative Care Improves QOL for Lung and GI Cancer Patients
  • Early Palliative Care Decreased Healthcare Use at End of Life

Resource Topics rightRail

  • Resource Topics
  • Partner Content
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Melanoma
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
3 Keys to Success in the Oncology Care Model

Current Issue

Oncology Vol 32 No 4
Apr 15, 2018 Vol 32 No 4
Digital Edition
Subscribe
Connect with Us
  • Twitter
  • Facebook
  • LinkedIn
  • RSS
Modern Medicine Network
  • Home
  • About Us
  • Advertise
  • Advertiser Terms
  • Privacy statement
  • Terms & Conditions
  • Editorial & Advertising Policy
  • Editorial Board
  • Contact Us
Modern Medicine Network
© UBM 2018, All rights reserved.
Reproduction in whole or in part is prohibited.